"Visitation restrictions are currently in place to decrease possible exposure to Coronavirus (COVID-19). Please visit our website for more information. CHI Health St. Francis is dedicated to delivering high quality, compassionate care to Grand Island and nearby communities. Visit us at 2620 W Faidley Ave or call (308) 384-4600 for more information."

During the past decade, CHI Health Saint Francis conducted 144 clinical trials. In the 10-year time frame, 144 clinical trials started and 97 clinical trials were completed, i.e. on average, 67.4% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 58 clinical trials were completed. i.e. 161.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHI Health Saint Francis" #1 sponsor was "National Cancer Institute (NCI)" with 118 trials, followed by "Alliance for Clinical Trials in Oncology" with 39 trials sponsored, "SWOG Cancer Research Network" with 35 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 18 trials sponsored and "NRG Oncology" with 18 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHI Health Saint Francis" #1 collaborator was "National Cancer Institute (NCI)" with 117 trials as a collaborator, "NRG Oncology" with 26 trials as a collaborator, "Canadian Cancer Trials Group" with 11 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator and "SWOG Cancer Research Network" with 7 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 42 trials.

According to Clinical.Site data, the most researched conditions in "CHI Health Saint Francis" are "Breast Cancer" (10 trials), "Invasive Breast Carcinoma" (9 trials), "Recurrent Ovarian Carcinoma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials) and "Stage IV Lung Cancer AJCC v8" (9 trials). Many other conditions were trialed in "CHI Health Saint Francis" in a lesser frequency.

Most popular intervention types in "CHI Health Saint Francis" are "Drug" (194 trials), "Other" (150 trials), "Biological" (108 trials), "Procedure" (63 trials) and "Radiation" (35 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (72 trials), "Quality-of-Life Assessment" (58 trials), "Questionnaire Administration" (39 trials), "Computed Tomography" (34 trials) and "Biospecimen Collection" (30 trials). Other intervention names were less common.

The vast majority of trials in "CHI Health Saint Francis" are 196 trials for "All" genders, 47 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "CHI Health Saint Francis". undefined are not yet recruiting, 62 are recruiting, 122 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 54 completed trials in CHI Health Saint Francis, 2 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in CHI Health Saint Francis, 6 "Phase 1" clinical trials were conducted, 108 "Phase 2" clinical trials and 133 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".